Loading...
Market
Will a public health advisory on estrogen therapy for transgender individuals be issued by Q1 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official advisory from a public health agency like the FDA or CDC
Story
Report Links Estrogen Hormone Therapy to Thyroid Cancer in Three Transgender Veterans
Oct 16, 2024, 04:10 PM
A recent report has linked hormone replacement therapy, specifically estrogen, to the development of thyroid cancer in three transgender military veterans. All three individuals, born male and identifying as female, underwent hormone therapy and subsequently were diagnosed with cancer. Medical professionals treating these patients noted that it is 'conceivable' that the hormone therapy could have contributed to their conditions, referencing previous research that associates estrogen with tumor growth. The report has prompted calls from doctors for further investigation into the safety of hormone treatments for transgender individuals.
View original story
Similar markets
Yes • 50%
No • 50%
Issue warning • 25%
Update guidelines • 25%
No changes • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Federal Legislation Passed • 25%
Executive Action Taken • 25%
Legal Challenges Initiated • 25%
No Significant Action • 25%
Predominantly Supportive • 25%
Predominantly Critical • 25%
Mixed Reactions • 25%
Minimal Reaction • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
